Skip to main content
Menu

IVISense Integrin Receptor 680 Fluorescent Probe (IntegriSense)

IVISense™ Integrin Receptor fluorescent probes target the αvβ3 integrin to visualize tumor growth, angiogenesis, and treatment response. This integrin plays a key role in cancer progression and immune evasion, making it a promising therapeutic target in immuno-oncology. As part of the broader integrin superfamily - cell surface receptors that regulate signaling, adhesion, and cell interactions - αvβ3 is especially relevant in diseases like cancer and atherosclerosis.

Feature Specification
Unit Size 1 vial (10 doses)
Specificity αVβ3 Integrin receptor

IVISense™ Integrin Receptor fluorescent probes target the αvβ3 integrin to visualize tumor growth, angiogenesis, and treatment response. This integrin plays a key role in cancer progression and immune evasion, making it a promising therapeutic target in immuno-oncology. As part of the broader integrin superfamily - cell surface receptors that regulate signaling, adhesion, and cell interactions - αvβ3 is especially relevant in diseases like cancer and atherosclerosis.

Product variants
Wave Length: 645 nm
Part #:
NEV10640
List price
USD 703.52
Your online price:
Wave Length: 680 nm
Part #:
NEV10645
List price
USD 682.67
Your online price:
Wave Length: 750 nm
Part #:
NEV10873
List price
USD 690.59
Your online price:
For research use only. Not for use in diagnostic procedures.

Loading...

Overview

IVISense Integrin Receptor 680 fluorescent imaging probe for in vivo detection of αvβ3 integrin is a low molecular weight peptidomimetic antagonist coupled to a red fluorochrome. This validated, high affinity (Kd = 4.2 nM) fluorescent probe has improved circulation half-life and specificity over RDG peptide-based agents, with selectivity 5-20x for αvβ3 integrin, for precise detection of αvβ3 integrins. This integrin-targeted molecular imaging agent enables non-invasive imaging to better understand biological processes, and disease biology and progression.

Including IVISense Integrin Receptor 680 fluorescent agent in careful experimental design allows for multiplexing with other channels and/or imaging times, and can be paired with other probes to achieve maximum efficiency and flexibility in your imaging studies.

Specifications

Brand
IVISense
Fluorescent Agent Type
Targeted
Imaging Modality
Fluorescence
Shipping Conditions
Shipped in Blue Ice
Specificity
αVβ3 Integrin receptor
Storage Conditions
-30 to -16 °C
Therapeutic Area
Angiogenesis
Atherosclerosis
Cardiovascular
Inflammation
Oncology
Pulmonary
Vascular
Unit Size
1 vial (10 doses)
Wave Length
680 nm

Resources

Are you looking for resources, click on the resource type to explore further.

1-6 of 8 Resources
Flyer Icon
Flyer
Best practices for designing an effective in vivo fluorescence imaging study

Fluorescence molecular imaging is the visualization of cellular and biological function in vivo to gain deeper insights into...

Application Brief Icon
Application Brief
Characterization of NIR fluorophores for their potential in non-specific tissue accumulation
eBook Icon
eBook
In vivo imaging solutions

Researchers trust our in vivo imaging solutions to give them reliable, calibrated data that reveals pathway characterization and...

Flyer Icon
Flyer
Integrins as targets for immunotherapy

Integrins are a superfamily of transmembrane cell surface receptors that mediate signal transduction, cell-to-cell interaction...

Guide Icon
Guide
IVISense fluorescent probe selector guide for oncology research

The goal of in vivo fluorescence molecular imaging is to enable non-invasive visualization and quantification of cellular and...

Application Note Icon
Application Note
Multiplex 2D imaging of NIR molecular imaging agents on the IVIS SpectrumCT platform

Epifluorescence (2D) imaging of superficially implanted mouse tumor xenograft models offers a fast and simple method for assessing...

Scroll Icon

Revvity AI Assistant Beta